Researchers evaluated the effects of SGLT2 inhibitors in protecting the kidneys, showing that the drugs might help improve oxygenation in these organs.
The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without ...